Study #2022-0989
18F-FSPG PET/CT as a non-invasive imaging biomarker for treatment response to chemoradiation in esophageal cancer
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study is being done to learn how 18F-FSPG PET/CT scan results may be related to the response to chemotherapy and radiation in patients with esophageal cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Esophageal Carcinoma
Study phase:
Physician name:
Steven Lin
Department:
Radiation Oncology
For general questions about clinical trials:
1-888-714-4981
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.